Yüklüyor......
Safety Strategies of Genetically Engineered T Cells in Cancer Immunotherapy
T-cell therapy using genetically engineered T cells modified with either T cell receptor or chi-meric antigen receptor holds great promise for cancer immunotherapy. The concerns about its toxicities still remain despite recent successes in clinical trials. Temporal and spatial control of the enginee...
Kaydedildi:
| Yayımlandı: | Curr Pharm Des |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Bentham Science Publishers
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5876919/ https://ncbi.nlm.nih.gov/pubmed/29283058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1381612824666171227222624 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|